Literature DB >> 22111164

[Myelodysplastic syndrome. What can be achieved with supportive therapy and new approaches].

Martin Bischoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22111164     DOI： 10.1007/bf03369015

Source DB:  PubMed          Journal:  MMW Fortschr Med        ISSN： 1438-3276


× No keyword cloud information.
  1 in total

1.  A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.

Authors:  Kai-Xun Hu; Qi-Yun Sun; Mei Guo; Jun-Xiao Qiao; Chang-Lin Yu; Jian-Hui Qiao; Zheng Dong; Wan-Jun Sun; Hong-Li Zuo; Ya-Jing Huang; Bo Cai; Hui-Sheng Ai
Journal:  Stem Cells Transl Med       Date:  2016-02-02       Impact factor: 6.940
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.